Publicaciones en las que colabora con MERCEDES ZUBIAUR MARCOS (15)

2017

  1. Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity

    Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 2, pp. 312-322

2016

  1. Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated with Visceral Leishmaniasis

    American Journal of Therapeutics, Vol. 23, Núm. 5, pp. e1193-e1196

2014

  1. Abnormal levels of expression of plasma MicroRNA-33 in patients with psoriasis

    Actas Dermo-Sifiliograficas, Vol. 105, Núm. 5, pp. 497-503

2013

  1. Decreased plasma levels of clusterin in patients with psoriasis

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 6, pp. 497-503

  2. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients

    Cytokine, Vol. 62, Núm. 2, pp. 232-243

  3. Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis.

    Journal of the European Academy of Dermatology and Venereology : JEADV, Vol. 27, Núm. 2, pp. 242-250

2012

  1. Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in Systemic Lupus Erythematosus patients

    Mediators of Inflammation, Vol. 2012

  2. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis

    European Journal of Dermatology, Vol. 22, Núm. 3, pp. 337-344

  3. Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: A proteomic signature for circulating low-density granulocytes

    Journal of Proteomics, Vol. 75, Núm. 6, pp. 1778-1791

2009

  1. Differential protein expression in peripheral blood mononuclear cells (PBMCs) on patients withd systemic lupus erythematosus (SLE)

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 116-116

2008

  1. Expresión diferencial de las cuatro isoformas de la proteína de unión a calcio S100A9 (Calgranulina B) en células mononucleares de sangre periférica de pacientes con lupus eritematoso sistémico respecto a controlos sanos

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 1, pp. 51-52

2006

  1. Increased association of CD38 with lipid rafts in T cells from patients with systemic lupus erythematosus and in activated normal T cells

    Molecular Immunology, Vol. 43, Núm. 7, pp. 1029-1039

  2. Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms.

    Proteomics, Vol. 6 Suppl 1

2003

  1. CD38 Signaling in T Cells Is Initiated within a Subset of Membrane Rafts Containing Lck and the CD3-ζ Subunit of the T Cell Antigen Receptor

    Journal of Biological Chemistry, Vol. 278, Núm. 50, pp. 50791-50802

2002

  1. CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-ζ immune receptor tyrosine-based activation motifs

    Journal of Biological Chemistry, Vol. 277, Núm. 1, pp. 13-22